新华制药: 关于公司副总经理辞职的公告

Core Viewpoint - The resignation of the Vice President of Shandong Xinhua Pharmaceutical Co., Ltd. is officially announced, and it is stated that this will not impact the company's normal operations [1] Group 1: Resignation Announcement - The company received a written resignation report from Vice President Zheng Zhonghui on September 5, 2025, due to personal reasons [1] - Zheng Zhonghui will not hold any executive position in the company after his resignation [1] - The resignation is effective immediately upon delivery to the board of directors [1] Group 2: Impact on Company Operations - As of the announcement date, Zheng Zhonghui has no outstanding commitments that he has failed to fulfill [1] - His resignation will not affect the company's normal production and operational activities [1] - There were no disagreements between Zheng Zhonghui and the board during his tenure [1] Group 3: Shareholding Information - Zheng Zhonghui holds 397,550 A shares of the company, and he will continue to manage his shares according to relevant laws and regulations after his resignation [1] - The board expresses gratitude for Zheng Zhonghui's contributions during his tenure [1]